Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
2.182
-0.058 (-2.60%)
Nov 17, 2026, 3:25 PM EST - Market open
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $280.65 thousand as of November 17, 2026. It is the 50,807th most valuable company in the world and the 7,030th biggest in the United States. Its market cap has decreased by 91.73% in one year.
Market Cap
280.65K
Enterprise Value
-4.00M
1-Year Change
-91.73%
Global Rank
Country Rank
#7,030 United States
Category
ChartMarket Cap Chart
Since March 17, 2022, Biodexa Pharmaceuticals's market cap has decreased from $13.70M to $280.65K, a decrease of -97.95%. That is a compound annual growth rate of -56.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 280.65K | -85.26% |
| Dec 31, 2025 | 1.90M | -19.06% |
| Dec 31, 2024 | 2.35M | -66.37% |
| Dec 29, 2023 | 6.99M | 121.92% |
| Dec 30, 2022 | 3.15M | -77.00% |
| Mar 17, 2022 | 13.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 908.01K |
| Oragenics | 893.37K |
| SciSparc | 814.66K |
| GeoVax Labs | 765.40K |
| Decoy Therapeutics | 590.32K |
| Scinai Immunotherapeutics | 546.84K |
| Lakewood-Amedex Biotherapeutics | 519.91K |
| Valion Bio | 469.54K |